CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma

Oral Oncology

Volumn 44, Issue 7, 2008, Pages 689-697

  Sathyan, K M ^a   Nalinakumari, K R ^a   Abraham, Thomas ^a   Kannan, S ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

A870G polymorphism; C1722G polymorphism; Cyclin D1; Oral cancer; Prognosis

Indexed keywords

CIS ACTING ELEMENT; CYCLIN D1;

ARTICLE; CANCER SURVIVAL; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNTRANSLATED REGION;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MOUTH NEOPLASMS; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 45249104366     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.09.003     Document Type: Article

References (30)

1. Parkin D.M., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J Clin 49 1 (1999) 33-64
2. Sankaranarayanan R., Masuyer E., Swaminathan R., Ferlay J., and Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18 (1998) 4779-4786
3. Casiglia J., and Woo S.B. A comprehensive review of oral cancer. Gen Dent 49 (2001) 72-82
4. Sherr C.J. D-type cyclins. Trends Biochem Sci 20 (1995) 187-190
5. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
6. Coqueret O. Linking cyclins to transcriptional control. Gene 299 (2002) 35-55
7. Fu M., Wang C., Li Z., Sakamaki T., and Pestell R.G. Minireview: cyclin D1: normal and abnormal functions. Endocrinology 145 (2004) 5439-5447
8. Jayasurya R., Sathyan K.M., Lakshminarayanan K., Abraham T., Nalinakumari K.R., Abraham E.K., et al. Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Mod Pathol 18 (2005) 1056-1066
9. Bova R.J., Quinn D.I., Nankervis J.S., Cole I.E., Sheridan B.F., Jensen M.J., et al. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 5 (1999) 2810-2819
10. Michalides R., van Veelen N., Hart A., Loftus B., Wientjens E., and Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55 (1995) 975-978
11. Betticher D.C., Thatcher N., Altermatt H.J., Hoban P., Ryder W.D., and Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11 (1995) 1005-1011
12. Knudsen K.E., Diehl J.A., Haiman C.A., and Knudsen E.S. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25 (2006) 1620-1628
13. Holley S.L., Heighway J., and Hoban P.R. Induced expression of human CCND1 alternative transcripts in mouse Cyl-1 knockout fibroblasts highlights functional differences. Int J Cancer 114 (2005) 364-370
14. Izzo J.G., Wu T.T., Wu X., Ensor J., Luthra R., Pan J., et al. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol 25 (2007) 698-707
15. Holley S.L., Parkes G., Matthias C., Bockmuhl U., Jahnke V., Leder K., et al. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 159 (2001) 1917-1924
16. Freier K., Joos S., Flechtenmacher C., Devens F., Benner A., Bosch F.X., et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63 (2003) 1179-1182
17. Huang Q., Yu G.P., McCormick S.A., Mo J., Datta B., Mahimkar M., et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Gene Chromosome Cancer 34 (2002) 224-233
18. Pastinen T., and Hudson T.J. Cis-acting regulatory variation in the human genome. Science 306 (2004) 647-650
19. Hosokawa Y., Suzuki R., Joh T., Maeda Y., Nakamura S., Kodera Y., et al. A small deletion in the 3′-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia. Int J Cancer 76 (1998) 791-796
20. Heighway J. HaeIII polymorphism within 3′ untranslated region of PRAD1. Nucleic Acids Res 19 (1991) 5451
21. Matthias C., Branigan K., Jahnke V., Leder K., Haas J., Heighway J., et al. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 4 (1998) 2411-2418
22. Shu X.O., Moore D.B., Cai Q., Cheng J., Wen W., Pierce L., et al. Association of cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev 14 (2005) 91-97
23. Sathyan K.M., Nalinakumari K.R., Abraham T., and Kannan S. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol 42 (2006) 607-613
24. Howe D., and Lynas C. The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica 86 (2001) 563-569
25. Izzo J.G., Papadimitrakopoulou V.A., Liu D.D., den Hollander P.L., Babenko I.M., Keck J., et al. Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst 95 (2003) 198-205
26. McKay J.A., Douglas J.J., Ross V.G., Curran S., Murray G.I., Cassidy J., et al. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen colorectal initiative. Int J Cancer 88 (2000) 77-81
27. Moreno-Bueno G., Rodriguez-Perales S., Sanchez-Estevez C., Hardisson D., Sarrio D., Prat J., et al. Cyclin D1 gene (CCND1) mutations in endometrial cancer. Oncogene 22 (2003) 6115-6118
28. Xu L., Davidson B.J., Murty V.V., Li R.G., Sacks P.G., Garin-Chesa P., et al. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer 59 (1994) 383-387
29. Ewen M.E., and Lamb J. The activities of cyclin D1 that drive tumorigenesis. Trends Mol Med 10 (2004) 158-162
30. Huang M., Spitz M.R., Gu J., Lee J.J., Lin J., Lippman S.M., et al. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 27 (2006) 2034-2037